14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.52 $2.35 Wednesday, 24th Apr 2024 CYCC stock ended at $2.30. This is 28.49% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 27.02% from a day low at $1.85 to a day high of $2.35.
90 days $1.52 $3.08
52 weeks $1.52 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Jan 05, 2024 $2.54 $2.90 $2.37 $2.49 545 218
Jan 04, 2024 $2.43 $2.50 $2.11 $2.27 70 864
Jan 03, 2024 $2.65 $2.65 $2.36 $2.39 79 856
Jan 02, 2024 $2.71 $2.74 $2.58 $2.65 70 642
Dec 29, 2023 $2.83 $3.06 $2.65 $2.67 213 692
Dec 28, 2023 $2.96 $3.09 $2.79 $2.84 184 359
Dec 27, 2023 $3.22 $3.35 $2.90 $2.90 150 556
Dec 26, 2023 $2.84 $2.98 $2.57 $2.81 61 517
Dec 22, 2023 $2.30 $3.00 $2.20 $2.74 220 058
Dec 21, 2023 $3.16 $3.76 $3.04 $3.60 287 151
Dec 20, 2023 $3.37 $3.51 $3.07 $3.19 66 776
Dec 19, 2023 $3.50 $3.73 $3.26 $3.37 149 115
Dec 18, 2023 $3.71 $4.38 $3.40 $3.69 337 075
Dec 15, 2023 $3.75 $3.89 $3.47 $3.58 13 346
Dec 14, 2023 $4.05 $4.05 $3.48 $3.71 13 349
Dec 13, 2023 $4.05 $4.05 $3.47 $3.66 21 103
Dec 12, 2023 $4.13 $4.15 $3.84 $4.11 12 910
Dec 11, 2023 $4.07 $4.12 $3.83 $4.08 8 576
Dec 08, 2023 $4.09 $4.17 $4.05 $4.07 5 012
Dec 07, 2023 $4.47 $4.47 $3.99 $4.05 10 574
Dec 06, 2023 $4.50 $4.50 $4.21 $4.37 13 685
Dec 05, 2023 $4.29 $4.65 $4.23 $4.64 10 876
Dec 04, 2023 $4.22 $4.47 $4.04 $4.40 13 033
Dec 01, 2023 $4.34 $4.70 $3.78 $4.05 30 093
Nov 30, 2023 $5.00 $6.00 $4.20 $4.50 155 909
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT